CBT Pharmaceuticals首獲澳洲倫理批准啟動APOLLO-1用於肝細胞性肝癌和腎細胞癌治療I/II期臨床試驗
August 08, 2018 08:50 ET
|
CBT Pharmaceuticals
美國加利福尼亞州普萊森頓及中國杭州, Aug. 08, 2018 (GLOBE NEWSWIRE) -- 致力於成為腫瘤綜合療法發現與開發領域的領先企業並在中美兩國均設有總部的創新性生物製藥公司CBT...
CBT Pharmaceuticals Receives First Australian Ethics Approval to Initiate APOLLO-1 Phase 1/2 Clinical Trial for Hepatocellular and Renal Cell Carcinoma
August 08, 2018 08:50 ET
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, China, Aug. 08, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the...
CBT Pharmaceuticals啟動以晚期實體瘤患者為物件的抗PD-1抗體CBT-501-01(Genolimzumab注射液)I期臨床試驗B階段
July 26, 2018 08:50 ET
|
CBT Pharmaceuticals
美國加利福尼亞州普萊森頓及中國浙江省杭州, July 26, 2018 (GLOBE NEWSWIRE) -- 在美國和中國均設有總部並致力成為腫瘤綜合療法研發領域領先企業的創新型生物製藥公司CBT...
CBT Pharmaceuticals启动以晚期实体瘤患者为对象的抗PD-1抗体CBT-501-01(Genolimzumab注射液)I期临床试验B阶段
July 26, 2018 08:50 ET
|
CBT Pharmaceuticals
美国加利福尼亚州普莱森顿及中国浙江省杭州市, July 26, 2018 (GLOBE NEWSWIRE) -- 在美国和中国均设有总部并致力于成为肿瘤综合疗法研发领域领军者的创新型生物制药公司CBT...
CBT Pharmaceuticals Initiates Phase 1b Clinical Trial for Anti-PD-1 Antibody CBT-501-01 (genolimzumab injection) in Patients with Advanced Solid Tumors
July 26, 2018 08:50 ET
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, ZHEJIANG, China, July 26, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a...